How does presence of MMR deficiency/Lynch syndrome affect your recommendation on peri-operative chemotherapy for high-grade upper tract urothelial cancer?  

Are MMR deficient tumors more resistant to cisplatin/carboplatin?



Answer from: Medical Oncologist at Community Practice